C. Payá

发表

Transcription of the RelB gene is regulated by NF-kappaB.

G. Bren, N. Solan, H. Miyoshi, 2001, Oncogene.

Transcriptional Regulation of the Human FasL Promoter-Enhancer Region*

Andrew D. Badley, C. Payá, C. J. Holtz-Heppelmann, 1998, The Journal of Biological Chemistry.

Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.

C. Payá, T. Griffith, D. Lynch, 1999, Journal of immunology.

Analytical Performance and Clinical Utility of a Nucleic Acid Sequence-Based Amplification Assay for Detection of Cytomegalovirus Infection

Thomas F. Smith, T. F. Smith, C. Ginocchio, 2000, Journal of Clinical Microbiology.

Potential Medical Impact of Endogenous Retroviruses

C. Payá, R. Abu-Nader, 2001 .

Fusarium infection after solid-organ transplantation.

C. Payá, P. Sampathkumar, Priya Sampathkumar, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Regulation of IkB alpha phosphorylation by PKC- and Ca(2+)-dependent signal transduction pathways.

E. A. O'neill, B. Frantz, G. Bren, 1995, Journal of immunology.

Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts.

Thomas F. Smith, T. F. Smith, W. Kremers, 2002, The Journal of infectious diseases.

LMP-1 activates NF-kappa B by targeting the inhibitory molecule I kappa B alpha

C. Payá, J. Herrero, P. Mathew, 1995, Journal of virology.

Protein Kinase C (PKC) Acts Upstream of PKC To Activate IB Kinase and NF-B in T Lymphocytes

K. N. Pennington, C. Payá, D. Savoy, 2003 .

Protein Kinase C and Calcineurin Synergize to Activate IκB Kinase and NF-κB in T Lymphocytes*

K. N. Pennington, C. Payá, A. Algeciras-Schimnich, 1999, Journal of Biological Chemistry.

G Protein-Coupled Chemokine Receptors Induce Both Survival and Apoptotic Signaling Pathways1

Timothy Gomez, Maria Vanegas, Maria Vanegas, 2002, The Journal of Immunology.

Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes.

C. Payá, R. Collman, G. Bou, 2001, The Journal of clinical investigation.

Repeatedly relapsing disseminated histoplasmosis: clinical observations during long-term follow-up.

C. Payá, R. Van Scoy, R. E. Ritts, 1987, The Journal of infectious diseases.

Antagonistic modulation of human cytomegalovirus replication by transforming growth factor beta and basic fibroblastic growth factor.

C. Payá, J. Alcamí, J. Virelizier, 1993, The Journal of general virology.

Constitutive Fas Ligand Gene Transcription in Sertoli Cells Is Regulated By Sp1*

C. Payá, R. McClure, C. Heppelmann, 1999, The Journal of Biological Chemistry.

Human herpesvirus‐6 and ‐7 in transplantation

C. Payá, D. Dockrell, 2001, Reviews in medical virology.

Human immunodeficiency virus-induced apoptosis of human hepatocytes via CXCR4.

G. Bren, C. Payá, T. Gomez, 2003, The Journal of infectious diseases.

Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations.

R. Wiesner, J. Ludwig, R. Krom, 1989, The Journal of infectious diseases.

Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.

R. Wiesner, C. Payá, M. Porayko, 1993, Gastroenterology clinics of North America.

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations.

T. F. Smith, R. Wiesner, R. Krom, 1989, Mayo Clinic proceedings.

Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients.

C. Payá, G. Roberts, R. Patel, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infections in solid-organ transplant recipients

C. Payá, R. Patel, Robin Patel, 1997, Clinical microbiology reviews.

Limited usefulness of quantitative culture of blood drawn through the device for diagnosis of intravascular-device-related bacteremia

M. Farnell, C. Payá, R. L. Thompson, 1989, Journal of clinical microbiology.

Safety and Efficacy of Nebulized Zanamivir in Hospitalized Patients with Serious Influenza

F. Hayden, M. Ison, R. Steigbigel, 2002, Antiviral therapy.

An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance

A. Humar, R. Freeman, C. Payá, 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Epitope Specific for an MHC Class II Promiscuous T Cells + Lymphoproliferation by CD 4 Inhibition of EBV-Induced

C. Payá, E. Celis, R. Omiya, 2002 .

Detection and Semiquantitative Analysis of Human Herpesvirus 8 DNA in Specimens from Patients with Kaposi’s Sarcoma

C. Payá, G. Procop, M. Espy, 1998, Journal of Clinical Microbiology.

Solid organ transplantation: Results and implications of acyclovir use in liver transplants

R. Wiesner, C. Payá, M. Porayko, 1993, Journal of medical virology.

Cytomegalovirus (CMV) Resistance to Antivirals

V. Emery, C. Payá, W. Drew, 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients

B. Alexander, M. Pescovitz, A. Humar, 2005, Transplantation.

Comparison of three methods for extraction of viral nucleic acids from blood cultures

C. Payá, M. Espy, T. F. Smith, 1995, Journal of clinical microbiology.

The Bile Acid Taurochenodeoxycholate Activates a Phosphatidylinositol 3-Kinase-dependent Survival Signaling Cascade*

G. Gores, R. Simari, L. Karnitz, 2000, The Journal of Biological Chemistry.

Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome.

J. Velosa, C. Payá, C. Lumbreras, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serine 32 and serine 36 of IκBα are directly phosphorylated by protein kinase CKII in Vitro

G. Bren, K. N. Pennington, C. Payá, 1999 .

Apoptosis Levels and Susceptibility to Fas-Mediated Cell Cycle-Dependent Regulation of FLIP

C. Payá, T. Griffith, D. Lynch, 1999 .

Iκκ Mediates NF-κB Activation in Human Immunodeficiency Virus-Infected Cells

G. Bren, C. Payá, S. Asin, 1999, Journal of Virology.

Ikk Mediates NF-kB Activation in Human Immunodeficiency Virus-Infected Cells

G. Bren, C. Payá, S. Asin, 1999 .

Modulation of T-cell activation through protein kinase C- or A-dependent signalling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteins

C. Payá, J. Virelizier, S. Michelson, 1991, Journal of virology.

RIIb) Targets I ε (FcSignal Transduction Pathway of CD23

C. Payá, S. Asin, R. Ten, 2013 .

The signal transduction pathway of CD23 (Fc epsilon RIIb) targets I kappa B kinase.

C. Payá, S. Asin, R. Ten, 1999, Journal of immunology.

Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation

G. Bren, C. Payá, R. Ten, 1999 .

Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients.

C. Payá, D. Dockrell, J. Strickler, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

required for its degradation. alpha at S-283, S-289, S-293, and T-291 and is Casein kinase II phosphorylates I kappa B

G. Bren, C. Payá, N. Chester, 2014 .

A Dominant Negative Protein Kinase C 4 Subspecies Blocks NF-vdB Activation

Lozano, C. Payá, J. Moscat, 2003 .

Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha.

Moses Rodriguez, C. Payá, M. Rodriguez, 1990, International immunology.

IκB Kinase-Dependent Chronic Activation of NF-κB Is Necessary for p21WAF1/Cip1 Inhibition of Differentiation-Induced Apoptosis of Monocytes

G. Bren, K. N. Pennington, C. Payá, 2001, Molecular and Cellular Biology.

PKC-?-associated CK2 participates in the turnover of free I?Ba 1 1 Edited by M. Yaniv

G. Bren, K. N. Pennington, C. Payá, 2000 .

Epstein-barr virus-induced posttransplant lymphoproliferative disorders

E. Kieff, T. Habermann, G. Gores, 1999 .

Pretransplantation assessment of the risk of lymphoproliferative disorder.

T. Habermann, R. Wiesner, J. Velosa, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function.

T. Craig, R. Kumar, F. Weih, 2003, The Journal of biological chemistry.

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

C. Payá, T. Schwab, J. Sarmiento, 2000, Clinical transplantation.

CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells

C. Payá, G. Bou, A. Algeciras-Schimnich, 2002, AIDS.

β-herpesviruses in transplantation

C. Payá, R. Razonable, 2002 .

The Signal Transduction Pathway of CD23 (FceRIIb) Targets IkB Kinase

C. Payá, S. Asin, R. Ten, 1999 .

Clinical Utility of Cytomegalovirus (CMV) Serology Testing in High‐risk CMV D+/R− Transplant Recipients

M. Pescovitz, A. Humar, C. Payá, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rapid shell vial culture and tissue histology compared with serology for the rapid diagnosis of cytomegalovirus infection in liver transplantation.

J. Ludwig, C. Payá, T. F. Smith, 1989, Mayo Clinic proceedings.

Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.

R. Wiesner, W. Harmsen, R. Krom, 1996, Transplantation.

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

C. Payá, V. Cuervas-Mons, A. R. Noriega, 1996, The Journal of infectious diseases.

T‐cell non‐hodgkin lymphoma in human immunodeficiency virus‐1‐infected individuals

P. Banks, G. Woloschak, C. Payá, 1989, American journal of hematology.

A Surveillance Study of Adenovirus Infection in Adult Solid Organ Transplant Recipients

Deepali Kumar, M. Pescovitz, A. Humar, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prevention of fungal and hepatitis virus infections in liver transplantation.

C. Payá, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevention of infections in solid organ transplant recipients

C. Payá, J. Villacian, 1999, Transplant infectious disease : an official journal of the Transplantation Society.

Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity.

C. Payá, P. Leibson, R. A. Schoon, 1988, Journal of immunology.

NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells.

R. Hay, C. Payá, J. Alcamí, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT

C. Lengerke, H. Einsele, C. Meisner, 2011, Bone Marrow Transplantation.

Serine 32 and serine 36 of IkappaBalpha are directly phosphorylated by protein kinase CKII in vitro.

J. Taylor, G. Bren, K. N. Pennington, 1999, Journal of molecular biology.

Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1

L. Picard, C. Payá, D. Danielpour, 1994, Journal of virology.

Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

J. Rabkin, R. Merion, M. Pescovitz, 2000, Antimicrobial Agents and Chemotherapy.

Detection of JNK and p38 activation by flow cytometry analysis.

C. Payá, G. Bou, A. Villasis-Keever, 2003, Analytical biochemistry.

Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts

C. Payá, R. Razonable, 2004, Expert review of anti-infective therapy.

Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis.

X. M. Chen, G. Gores, N. LaRusso, 2001, Gastroenterology.

Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.

G. Gores, N. LaRusso, C. Payá, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism.

X. M. Chen, G. Gores, N. LaRusso, 1999, The American journal of physiology.

Human herpesvirus 6.

C. Payá, T. F. Smith, D. Dockrell, 1999, Mayo Clinic proceedings.

Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number.

C. Payá, A. Badley, D. Lynch, 1999, AIDS research and human retroviruses.

Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus.

Moses Rodriguez, C. Payá, M. Rodriguez, 1989, Journal of immunology.

Human β-Herpesvirus Interactions in Solid Organ Transplant Recipients

Thomas F. Smith, T. F. Smith, W. Harmsen, 2001 .

Diagnosis of cytomegalovirus hepatitis by histopathology and in situ hybridization in liver transplantation.

R. Wiesner, J. Ludwig, C. Payá, 1991, Diagnostic microbiology and infectious disease.

Prevention of fungal infection in transplantation.

C. Payá, 2002, Transplant infectious disease : an official journal of the Transplantation Society.

A longitudinal molecular surveillance study of human polyomavirus viremia in heart, kidney, liver, and pancreas transplant patients.

A. Humar, C. Payá, E. Alecock, 2005, The Journal of infectious diseases.

Optimal Length of Valganciclovir Prophylaxis after Solid Organ Transplantation

C. Payá, R. Razonable, A. Eid, 2008 .

Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection

Thomas F. Smith, T. F. Smith, W. Kremers, 2003, Clinical transplantation.

Fungal infections in liver transplantation: prophylaxis, surveillance, and treatment

C. Payá, R. Razonable, 2002 .

Management of cytomegalovirus infection after liver transplantation

C. Payá, P. Sampathkumar, 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Association Between Toll-Like Receptor Polymorphisms and the Outcome of Liver Transplantation for Chronic Hepatitis C Virus

C. Payá, R. Razonable, Robert A. Brown, 2007, Transplantation.

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients.

T. F. Smith, R. Wiesner, W. Harmsen, 1999, Transplantation.

Stimulation of toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines.

C. Payá, R. Razonable, Martin Hénault, 2006, Toxicology and applied pharmacology.

Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: Role of immunostaining, dna hybridization and culture of hepatic tissue

Thomas F. Smith, K. Batts, R. Wiesner, 1990, Hepatology.

NF-κB cis-Acting Motifs of the Human Immunodeficiency Virus (HIV) Long Terminal Repeat Regulate HIV Transcription in Human Macrophages

G. Bren, N. Solan, C. Payá, 2001, Journal of Virology.

Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient.

R. Wiesner, C. Payá, G. Roberts, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nystatin Induces Secretion of Interleukin (IL)-1β, IL-8, and Tumor Necrosis Factor Alpha by a Toll-Like Receptor-Dependent Mechanism

C. Payá, R. Razonable, H. Watson, 2005, Antimicrobial Agents and Chemotherapy.

Laboratory methods for the diagnosis of disseminated histoplasmosis: clinical importance of the lysis-centrifugation blood culture technique.

C. Payá, F. Cockerill, G. Roberts, 1987, Mayo Clinic proceedings.

Transient fungemia in acute pulmonary histoplasmosis: detection by new blood-culturing techniques.

C. Payá, F. Cockerill, G. Roberts, 1987, Journal of Infectious Diseases.

Fungal infections in solid-organ transplantation.

C. Payá, C V Paya, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungal infections in solid organ transplant recipients.

C. Payá, P. Ljungman, J. Tollemar, 1998 .

Secretion of Proinflammatory Cytokines and Chemokines during Amphotericin B Exposure Is Mediated by Coactivation of Toll-Like Receptors 1 and 2

Linda N. Lee, C. Payá, P. Johnston, 2005, Antimicrobial Agents and Chemotherapy.

Phaeohyphomycosis Due to Scopulariopsis brumptii in a

C. Payá, 1994 .

Definitions of cytomegalovirus infection and disease in transplant recipients.

P. Griffiths, C. Payá, P. Ljungman, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.

R. Wiesner, C. Payá, A. Badley, 1997, Transplantation.

Cytomegalovirus prophylaxis in solid organ transplant recipients.

D. Snydman, R. Rubin, M. Pescovitz, 1996, Transplantation.

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis.

T. F. Smith, R. Wiesner, R. Krom, 1993, Journal of hepatology.

Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections.

C. Payá, R. Razonable, 2003, Herpes : the journal of the IHMF.

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

B. Alexander, M. Pescovitz, A. Humar, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Infection in transplantation

C. Payá, 1999 .

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

R. Wiesner, J. Griffith, D. Snydman, 1998, Transplantation.

Prevention of cytomegalovirus disease in recipients of solid-organ transplants.

D. Snydman, C. Payá, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prophylaxis for CMV should now replace pre‐emptive therapy in solid organ transplantation

C. Payá, G. Hart, 2001, Reviews in medical virology.

Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients

C. Payá, R. Delgado, A. R. Noriega, 1992, Journal of clinical microbiology.

Optimization of detection of cytomegalovirus viremia in transplantation recipients by shell vial assay

W. Harmsen, C. Payá, D. Ilstrup, 1995, Journal of clinical microbiology.

Bacterial infections after liver transplantation

C. Payá, P. Hermans, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Detection of cytomegalovirus infections in specimens other than urine by the shell vial assay and conventional tube cell cultures

C. Payá, T. F. Smith, A. D. Wold, 1987, Journal of clinical microbiology.

The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease.

Thomas F. Smith, T. F. Smith, W. Kremers, 2002, Transplantation.

Comparative Quantitation of Cytomegalovirus (CMV) DNA in Solid Organ Transplant Recipients with CMV Infection by Using Two High-Throughput Automated Systems

Thomas F. Smith, T. F. Smith, W. Kremers, 2001, Journal of Clinical Microbiology.

Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients

Thomas F. Smith, T. F. Smith, C. Payá, 2002, Journal of Clinical Microbiology.

Evaluation of PCR Primers for Early Diagnosis of Cytomegalovirus Infection following Liver Transplantation

Thomas F. Smith, T. F. Smith, C. Payá, 1998, Journal of Clinical Microbiology.

Clinical Utility of Cytomegalovirus Viral Load Testing for Predicting CMV Disease in D+/R‐ Solid Organ Transplant Recipients

B. Alexander, M. Pescovitz, A. Humar, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation.

T. F. Smith, J A Wilson, I. Sia, 2000, The Journal of infectious diseases.

Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation.

R. Wiesner, C. Payá, M. Espy, 1998, Transplantation.

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.

B. Alexander, M. Pescovitz, A. Humar, 2004, The Journal of infectious diseases.

Risk Factors for Cytomegalovirus Viremia and Disease Developing after Prophylaxis in High-Risk Solid-Organ Transplant Recipients

B. Alexander, M. Pescovitz, A. Humar, 2004, Transplantation.

Evaluation of number of shell vial cell cultures per clinical specimen for rapid diagnosis of cytomegalovirus infection

C. Payá, D. Ilstrup, T. F. Smith, 1988, Journal of clinical microbiology.

The pathogenesis of hepatitis C virus is influenced by cytomegalovirus.

Thomas F. Smith, T. F. Smith, R. Wiesner, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C

K. Batts, R. Wiesner, W. Kremers, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Apoptosis in AIDS.

C. Payá, A. Badley, D. Dockrell, 1997, Advances in pharmacology.

Rol eo fth eLaborator yi nDiagnosi san dManagemen tof Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients

Thomas F. Smith, C. Payá, R. Razonable, 2002 .

Economic impact of cytomegalovirus in solid organ transplantation

C. Payá, 2001, Transplant infectious disease : an official journal of the Transplantation Society.

The impact of human herpesvirus‐6 and ‐7 infection on the outcome of liver transplantation

C. Payá, R. Razonable, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease.

R. Wiesner, W. Harmsen, R. Krom, 1997, The Journal of infectious diseases.

Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation

Thomas F. Smith, T. F. Smith, R. Wiesner, 1992, Hepatology.

Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients

C. Payá, A. Feldstein, M. El‐Youssef, 2003, Pediatric transplantation.

Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease.

A. Humar, C. Payá, E. Alecock, 2005, The Journal of infectious diseases.

Relevance and risk factors of enterococcal bacteremia following liver transplantation.

R. Wiesner, W. Harmsen, R. Krom, 1996, Transplantation.

Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation.

C. Payá, R. Razonable, Robert A. Brown, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

Thomas F. Smith, T. F. Smith, I. Sia, 2002, The Journal of infectious diseases.

CD4 Regulates Susceptibility to Fas ligand– and Tumor Necrosis Factor–mediated Apoptosis

C. Payá, A. Algeciras, D. Lynch, 1998, The Journal of experimental medicine.

Human Immunodeficiency Virus Induces a Dual Regulation of Bcl-2, Resulting in Persistent Infection of CD4+ T- or Monocytic Cell Lines

F. Barré-Sinoussi, M. Nugeyre, H. Masutani, 1998, Journal of Virology.

Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes

C. Payá, A. Badley, D. Lynch, 1996, Journal of virology.

RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100*

G. Bren, N. Solan, H. Miyoshi, 2002, The Journal of Biological Chemistry.

Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation

G. Bren, C. Payá, N. Chester, 1996, Molecular and cellular biology.

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir.

T. Larson, C. Payá, A. Rivero, 2001, The Journal of infectious diseases.

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.

E. A. O'neill, R. Kincaid, B. Frantz, 1994, The EMBO journal.

EFFICACY OF GANCICLOVIR IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS WITH SEVERE CYTOMEGALOVIRUS INFECTION

Thomas F. Smith, T. F. Smith, R. Wiesner, 1988, Transplantation.

Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.

T. Habermann, R. Wiesner, R. Walker, 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.

T. Habermann, R. Wiesner, J. Velosa, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients

Barbara Alexander, Nigel Heaton, B. Alexander, 2005, Clinical pharmacokinetics.

Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus

G. Bren, C. Payá, W. S. MacMorran, 1995, Journal of virology.

PKC-zeta-associated CK2 participates in the turnover of free IkappaBalpha.

G. Bren, K. N. Pennington, C. Payá, 2000, Journal of molecular biology.

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.

R. Wiesner, R. Krom, C. Payá, 1995, The Journal of infectious diseases.

Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir.

Thomas F. Smith, T. F. Smith, R. Wiesner, 2003, The Journal of infectious diseases.

A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation

C. Payá, C. Hughes, D. Mulligan, 2002, Transplantation.

Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1.

J. Alam, C. Payá, J. Grande, 2001, Kidney international.

Evaluation of the COBAS AMPLICOR CMV MONITOR Test for Detection of Viral DNA in Specimens Taken from Patients after Liver Transplantation

Thomas F. Smith, T. F. Smith, I. Sia, 2000, Journal of Clinical Microbiology.

Indirect effects of CMV in the solid organ transplant patient.

C. Payá, 1999, Transplant infectious disease : an official journal of the Transplantation Society.

The economic impact of cytomegalovirus infection after liver transplantation.

W. Kim, E. Dickson, R. Wiesner, 2000, Transplantation.

Infectious complications following renal transplantation.

I. Sia, C. Payá, 1998, The Surgical clinics of North America.

Transcription of the RelB gene is regulated by NF-κB

G. Bren, N. Solan, H. Miyoshi, 2001, Oncogene.

IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes.

J. Taylor, G. Bren, K. N. Pennington, 2001, Molecular and cellular biology.

Ikappakappa mediates NF-kappaB activation in human immunodeficiency virus-infected cells.

J. Taylor, G. Bren, C. Payá, 1999, Journal of virology.

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.

E. Kieff, T. Habermann, C. Payá, 1999, Transplantation.

In vivo analysis of Fas/FasL interactions in HIV-infected patients.

M. Lederman, D. Kuritzkes, H. Kessler, 1998, The Journal of clinical investigation.

Human Immunodeficiency Virus Reactivation by Phorbol Esters or T-Cell Receptor Ligation Requires both PKCα and PKCθ

G. Bren, K. N. Pennington, C. Payá, 2005, Journal of Virology.

Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes

G. Bren, C. Payá, M. Diaz-Meco, 1996, Journal of virology.

Effacing of the T Cell Compartment by Cardiac Transplantation in Infancy1

D. Driscoll, J. Platt, C. Payá, 2006, The Journal of Immunology.

Cardiac Transplantation in Infancy Effacing of the T Cell Compartment by

C. Payá, R. Razonable, D. West, 2022 .

Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation.

T. F. Smith, C. Payá, G. Procop, 1999, Transplantation.

Activation of IκB Kinase β by Protein Kinase C Isoforms

G. Bren, C. Payá, M. Diaz-Meco, 1999, Molecular and Cellular Biology.

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients.

R. Wiesner, C. Payá, M. Espy, 1995, The Journal of infectious diseases.

Detection of cytomegalovirus DNA in sera of liver transplant recipients

R. Wiesner, C. Payá, M. Espy, 1994, Journal of clinical microbiology.

The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B

G. Bren, C. Payá, A. Algeciras, 1996, Journal of virology.

The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection.

C. Payá, A. Algeciras, A. Badley, 1998, The Journal of clinical investigation.

A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation

Lozano, C. Payá, M. Diaz-Meco, 1993, Molecular and cellular biology.

Detection of cytomegalovirus from blood leukocytes separated by sepracell-MN and Ficoll-Paque/Macrodex methods

C. Payá, T. F. Smith, A. D. Wold, 1988, Journal of clinical microbiology.

Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor

C. Payá, A. Badley, D. Lynch, 1997, The Journal of experimental medicine.

Inhibition of EBV-Induced Lymphoproliferation by CD4+ T Cells Specific for an MHC Class II Promiscuous Epitope1

Hiroya Kobayashi, C. Payá, E. Celis, 2002, The Journal of Immunology.

Clinical evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay in liver transplant recipients.

R. Wiesner, T. Lazzarotto, C. Payá, 2001, Transplantation.

Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.

C. Payá, P. Leibson, R. A. Schoon, 1990, Journal of immunology.

Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes

R. Wiesner, S. Nyberg, J. Platt, 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes

R. Wiesner, S. Nyberg, J. Platt, 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome.

R. Wiesner, J. Ludwig, C. Payá, 1991, Transplantation proceedings.

Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients.

R. Wiesner, W. Harmsen, C. Payá, 1996, The Journal of infectious diseases.

The Signal Transduction Pathway of CD23 (FcεRIIb) Targets IκB Kinase

C. Payá, S. Asin, R. Ten, 1999, Journal of Immunology.

Fungal infections after marrow transplantation.

C. Payá, P. Ljungman, R. Bowden, 1998 .

Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.

J. Velosa, C. Payá, J. Nguyen, 1998, Clinical transplantation.

Novel mutation in the CMV UL97 gene associated with resistance to ganciclovir therapy.

I. Sia, S. Chou, C. Payá, 1999, Transplantation.